Michele Biagioli
Università degli Studi di Perugia
H-index: 24
Europe-Italy
Top articles of Michele Biagioli
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis
Biochemical Pharmacology
2024/5/1
A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease
bioRxiv
2024
Bile acids and bile acid activated receptors in the treatment of COVID-19
2023/12/9
Stefano Fiorucci
H-Index: 44
Michele Biagioli
H-Index: 13
Valentina Sepe
H-Index: 17
Angela Zampella
H-Index: 24
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of …
Journal of the American Heart Association
2023/12/5
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease
Biochemical Pharmacology
2023/12/1
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
ACS omega
2023/11/16
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer
Cellular Oncology
2023/11/9
Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders
2023/9/1
Stefano Fiorucci
H-Index: 44
Valentina Sepe
H-Index: 17
Michele Biagioli
H-Index: 13
Angela Zampella
H-Index: 24
Combinatorial targeting of G‐protein‐coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug …
Hepatology
2023/7/1
Mo1239 MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION BY LIF VIA STAT3 PHOSPHORILATION IN GASTRIC CANCER
Gastroenterology
2023/5/1
Sa1749 DISCOVERY OF NEW MOLECULE; AGONIST OF GPBAR1 AND INVERSE AGONIST OF RORΓT, FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
Gastroenterology
2023/5/1
Michele Biagioli
H-Index: 13
Cristina Di Giorgio
H-Index: 5
Angela Zampella
H-Index: 24
Stefano Fiorucci
H-Index: 44
Su1416 NATURAL AND SYNTHETIC BILE ACIDS FUNCTION AS LEUKEMYA INHIBITORY FACTOR RECEPTOR (LIFR) ANTAGONISTS AND REVERT PROLIFERATION AND MIGRATION IN PANCREATIC CANCER CELL LINES
Gastroenterology
2023/5/1
217 BAR502, A DUAL FXR AND GPBAR1 AGONIST, SYNERGIZED ATORVASTATIN BENEFICIAL EFFECTS ON VASCULAR INFLAMMATION IN NASH
Gastroenterology
2023/5/1
Michele Biagioli
H-Index: 13
Cristina Di Giorgio
H-Index: 5
Angela Zampella
H-Index: 24
Stefano Fiorucci
H-Index: 44
Modeling inflammatory bowel disease by intestinal organoids
2023/5/1
Cristina Di Giorgio
H-Index: 5
Michele Biagioli
H-Index: 13
Angela Zampella
H-Index: 24
Annibale Donini
H-Index: 25
Stefano Fiorucci
H-Index: 44
Expanding the Library of 1, 2, 4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists
Molecules
2023/3/21
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
Frontiers in Oncology
2023/3/14
Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders
ACS omega
2023/1/31
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
Scientific reports
2023/1/28
Michele Biagioli
H-Index: 13
Cristina Di Giorgio
H-Index: 5
Angela Zampella
H-Index: 24
Stefano Fiorucci
H-Index: 44
Immunomodulatory functions of FXR
Molecular and Cellular Endocrinology
2022/7/1
Next-generation sequencing analysis of gastric cancer identifies the leukemia inhibitory factor receptor as a driving factor in gastric cancer progression and as a predictor of …
Frontiers in Oncology
2022/6/30
